Skip to main content

Coronavirus: Vaccination

Question for Department of Health and Social Care

UIN HL10303, tabled on 12 November 2020

To ask Her Majesty's Government what assessment they have made of the potential reliance on paracetamol in alleviating possible side effects of the COVID-19 vaccination; what plans they have to ensure that patients in rural areas can access such medication where there is no community pharmacy in place; and whether rural dispensing practices will be permitted to sell sufficient quantities of such medication.

Answered on

30 November 2020

Assessments on the potential reliance on medication in alleviating possible side effects of the COVID-19 vaccination are not finalised as we do not yet know the full characteristics, including side effects, of any of the vaccines in development. All plans for deployment remain flexible as there are no certainties in the development, production, formulation and timing of any new vaccines.

Detailed planning is underway building on the National Health Service’s expertise to deliver immunisation programmes, such as the flu vaccination programme. Planning considerations, includes the supporting infrastructure required, including warehousing, transport, logistics for transport across the nation and end-destination ‘clinic’ storage.

Medication such as paracetamol can also be purchased from supermarkets and other retail outlets, as a ‘general sales’ medicine. Paracetamol can also be purchased online, including in a larger quantity from an online pharmacy.